EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses

Hsiao-Chien Lo, Hsuuw Yan-Der, Pei-Ling Chang, Mao-Yuan Lin, So Kee

Veterinary and Animal Science · 2026-12 · 34 · 100777

DOI: 10.1016/j.vas.2026.100777 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Veterinary and Animal Science, 2026-12. Verfasst von Hsiao-Chien Lo und 4 weiteren Autor:innen. Beteiligte Einrichtung: 20 Cents Equine Practice, No. 10, Liaoning 1st St., Sanmin Dist., Kaohsiung 807020, Taiwan. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Equine neoplasia, including sarcoids, melanomas, and squamous cell carcinomas, presents therapeutic challenges due to recurrence and limitations of conventional treatments. Para-toluenesulfonamide (p-TLS) is a tumor-ablating agent that is associated with localized tumor necrosis and subsequent lesion resolution. It has been evaluated in human clinical settings as an intratumoral treatment of malignant airway obstruction caused by non-small cell lung cancer. This study aimed to describe the clinical outcomes and tolerability of intratumoral p-TLS in equine neoplasia. Three equine cases, including a fibroblastic sarcoid, perianal melanoma, and penile squamous cell carcinoma, were treated. The fibroblastic sarcoid and penile squamous cell carcinoma achieved complete response. The melanoma fulfilled the criteria for partial response at the protocol-defined clinical evaluation timepoint and subsequently demonstrated complete clinical resolution during follow-up. All cases demonstrated a consistent pattern of response characterized by tumor necrosis, sloughing, and subsequent wound healing with complete re-epithelialization. Local adverse effects were limited to transient inflammation and mild discomfort, which were effectively managed with supportive care. No severe adverse events or tumor recurrence were observed during the follow-up period ranging from 120 days to 15 months. These findings suggest that p-TLS may represent a feasible, highly minimally invasive intratumoral therapeutic approach for equine neoplasia and support further evaluation.

Schlagwörter

Stichwörter der Autor:innen

EquineIntratumoral therapyMelanomaNeoplasiaPara-toluenesulfonamideSarcoidSquamous cell carcinoma

Autor:innen und Institutionen

  • 20 Cents Equine Practice, No. 10, Liaoning 1st St., Sanmin Dist., Kaohsiung 807020, Taiwan.
  • Department of Biological Science and Technology, National Pingtung University of Science and Technology, No. 1, Xuefu Road, Neipu Township, Pingtung County 91201, Taiwan.
  • Gongwin Pet Biopharm Co., Ltd. 3F, No. 80, Sec 1, Jianguo North Road, Zhongshan District, Taipei 10491, Taiwan.

Zitieren

APA

Lo, H. C., Yan-Der, H., Chang, P. L., Lin, M. Y., & Kee, S. (2026). Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses. Veterinary and Animal Science, 34, 100777. https://doi.org/10.1016/j.vas.2026.100777

Vancouver

Lo HC, Yan-Der H, Chang PL, Lin MY, Kee S. Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses. Veterinary and Animal Science. 2026;34:100777. doi:10.1016/j.vas.2026.100777

BibTeX
@article{Lo2026,
  author = {Lo, Hsiao-Chien and Yan-Der, Hsuuw and Chang, Pei-Ling and Lin, Mao-Yuan and Kee, So},
  title = {Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses},
  journal = {Veterinary and Animal Science},
  year = {2026},
  volume = {34},
  pages = {100777},
  doi = {10.1016/j.vas.2026.100777}
}
Kostenlos starten →